AMRX
Price
$7.47
Change
+$0.30 (+4.18%)
Updated
Jun 6, 04:09 PM (EDT)
Capitalization
1.87B
62 days until earnings call
EBS
Price
$6.58
Change
+$0.52 (+8.60%)
Updated
Jun 6, 04:17 PM (EDT)
Capitalization
120.07M
67 days until earnings call
Interact to see
Advertisement

AMRX vs EBS

Header iconAMRX vs EBS Comparison
Open Charts AMRX vs EBSBanner chart's image
Amneal Pharmaceuticals
Price$7.47
Change+$0.30 (+4.18%)
Volume$100
Capitalization1.87B
Emergent Biosolutions
Price$6.58
Change+$0.52 (+8.60%)
Volume$200
Capitalization120.07M
AMRX vs EBS Comparison Chart
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. EBS commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Hold and EBS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (AMRX: $7.17 vs. EBS: $6.05)
Brand notoriety: AMRX and EBS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 79% vs. EBS: 90%
Market capitalization -- AMRX: $1.87B vs. EBS: $120.07M
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. EBS’s [@Pharmaceuticals: Other] market capitalization is $120.07M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whileEBS’s FA Score has 1 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • EBS’s FA Score: 1 green, 4 red.
According to our system of comparison, EBS is a better buy in the long-term than AMRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 3 TA indicator(s) are bullish while EBS’s TA Score has 5 bullish TA indicator(s).

  • AMRX’s TA Score: 3 bullish, 4 bearish.
  • EBS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, EBS is a better buy in the short-term than AMRX.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а -1.78% price change this week, while EBS (@Pharmaceuticals: Other) price change was -6.35% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +79.42%. For the same industry, the average monthly price growth was +16.29%, and the average quarterly price growth was +67.54%.

Reported Earning Dates

AMRX is expected to report earnings on Aug 07, 2025.

EBS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+79.42% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRX($1.87B) has a higher market cap than EBS($120M). AMRX has higher P/E ratio than EBS: AMRX (90.00) vs EBS (17.73). AMRX YTD gains are higher at: -9.470 vs. EBS (-36.715). AMRX has higher annual earnings (EBITDA): 400M vs. EBS (-518.2M). EBS has more cash in the bank: 112M vs. AMRX (91.5M). EBS has less debt than AMRX: EBS (860M) vs AMRX (2.75B). AMRX has higher revenues than EBS: AMRX (2.39B) vs EBS (1.02B).
AMRXEBSAMRX / EBS
Capitalization1.87B120M1,558%
EBITDA400M-518.2M-77%
Gain YTD-9.470-36.71526%
P/E Ratio90.0017.73508%
Revenue2.39B1.02B234%
Total Cash91.5M112M82%
Total Debt2.75B860M320%
FUNDAMENTALS RATINGS
AMRX vs EBS: Fundamental Ratings
AMRX
EBS
OUTLOOK RATING
1..100
6167
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
65100
SMR RATING
1..100
9694
PRICE GROWTH RATING
1..100
6245
P/E GROWTH RATING
1..100
2311
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EBS's Valuation (55) in the Biotechnology industry is somewhat better than the same rating for AMRX (92) in the Pharmaceuticals Major industry. This means that EBS’s stock grew somewhat faster than AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (65) in the Pharmaceuticals Major industry is somewhat better than the same rating for EBS (100) in the Biotechnology industry. This means that AMRX’s stock grew somewhat faster than EBS’s over the last 12 months.

EBS's SMR Rating (94) in the Biotechnology industry is in the same range as AMRX (96) in the Pharmaceuticals Major industry. This means that EBS’s stock grew similarly to AMRX’s over the last 12 months.

EBS's Price Growth Rating (45) in the Biotechnology industry is in the same range as AMRX (62) in the Pharmaceuticals Major industry. This means that EBS’s stock grew similarly to AMRX’s over the last 12 months.

EBS's P/E Growth Rating (11) in the Biotechnology industry is in the same range as AMRX (23) in the Pharmaceuticals Major industry. This means that EBS’s stock grew similarly to AMRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXEBS
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 18 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANGPY6.840.56
+8.92%
Valterra Platinum Ltd
CSCCF5.830.18
+3.13%
CAPSTONE COPPER CORP.
RMRDF0.28N/A
+1.44%
Radisson Mining Resources Inc.
DTRUY21.490.08
+0.39%
DAIMLER TRUCK HLDG AG
BACHY14.650.05
+0.34%
Bank of China, Ltd.

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with PAHC. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
-0.55%
PAHC - AMRX
46%
Loosely correlated
-0.35%
HROW - AMRX
46%
Loosely correlated
-2.68%
VTRS - AMRX
40%
Loosely correlated
-1.63%
ZTS - AMRX
38%
Loosely correlated
+0.01%
AMPH - AMRX
38%
Loosely correlated
-1.31%
More

EBS and

Correlation & Price change

A.I.dvisor indicates that over the last year, EBS has been loosely correlated with HROW. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if EBS jumps, then HROW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EBS
1D Price
Change %
EBS100%
-4.42%
HROW - EBS
37%
Loosely correlated
-2.68%
AMRX - EBS
36%
Loosely correlated
-0.55%
SIGA - EBS
32%
Poorly correlated
-4.39%
VTRS - EBS
29%
Poorly correlated
-1.63%
ZOMDF - EBS
29%
Poorly correlated
+3.30%
More